Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
GLP-1 Therapies and Risk of Muscle Loss Glucagon-like peptide-1 (GLP-1) medications have increasingly been prescribed to treat cardiometabolic conditions such as obesity, diabetes, and cardiovascular diseasesYeo et al (2024) conducted a nationwide analysis on the usage of GLP-1's in patients without diabetes and observed a 700% (from 21,000 in 2019 to 174,000 in 2023) increase between the years 2019-2023
Patients should be cautious about products that promise rapid weight loss, dramatic appetite suppression, or results equal to prescription injections without medical supervision
This leads to increased satiety, reduced hunger, and delayed gastric emptying (an effect that may diminish over time), which collectively contribute to significant weight loss
Its little eyes lay flush against beaded, scaly skin
This prevents misunderstandings if semaglutide appears on the test
Similarly, if youre seeing excellent results at your current dose, theres no rush to increase
